Mark Weinstein

5.1k total citations · 2 hit papers
53 papers, 3.8k citations indexed

About

Mark Weinstein is a scholar working on Hematology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark Weinstein has authored 53 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 13 papers in Surgery and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark Weinstein's work include Platelet Disorders and Treatments (18 papers), Hemophilia Treatment and Research (10 papers) and Blood properties and coagulation (6 papers). Mark Weinstein is often cited by papers focused on Platelet Disorders and Treatments (18 papers), Hemophilia Treatment and Research (10 papers) and Blood properties and coagulation (6 papers). Mark Weinstein collaborates with scholars based in United States, United Kingdom and Netherlands. Mark Weinstein's co-authors include Daniel Deykin, Joseph H. Troll, Joel L. Moake, Christine K. Rudy, Suchen L. Hong, José Azócar, Richard H. Seder, E W Salzman, Thomas L. Ortel and William L. Nichols and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Mark Weinstein

53 papers receiving 3.6k citations

Hit Papers

Unusually Large Plasma Factor VIII: von Willebrand Factor... 1982 2026 1996 2011 1982 2008 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Unusually Large Plasma Factor VIII: von Willebrand Factor Multimers in Chronic Relapsing Thrombotic Thrombocytopenic Purpura
    1982 845 citations Joel L. Moake, Christine K. Rudy et al. profile →
  2. von Willebrand disease (VWD): evidence‐based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA) 1
    2008 630 citations William L. Nichols, MB Hultin et al. Haemophilia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Weinstein United States 25 2.0k 933 741 615 473 53 3.8k
Barbara M. Alving United States 32 2.2k 1.1× 458 0.5× 884 1.2× 638 1.0× 366 0.8× 107 4.7k
H K Nieuwenhuis Netherlands 44 3.6k 1.8× 768 0.8× 1.0k 1.4× 864 1.4× 566 1.2× 101 6.3k
Catherine P.M. Hayward Canada 42 4.4k 2.2× 644 0.7× 1.8k 2.4× 905 1.5× 694 1.5× 165 6.4k
Rodger L. Bick United States 41 2.2k 1.1× 236 0.3× 1.1k 1.5× 711 1.2× 361 0.8× 180 4.5k
Paul Knöbl Austria 42 3.2k 1.6× 2.0k 2.1× 497 0.7× 345 0.6× 1.2k 2.5× 159 5.6k
Elaine M. Sloand United States 43 2.5k 1.3× 1.4k 1.5× 283 0.4× 233 0.4× 785 1.7× 117 4.8k
Volker Witt Austria 21 1.0k 0.5× 967 1.0× 456 0.6× 360 0.6× 598 1.3× 61 3.4k
PM Mannucci Italy 37 3.0k 1.5× 455 0.5× 701 0.9× 495 0.8× 608 1.3× 116 4.2k
Bas de Laat Netherlands 37 2.7k 1.3× 747 0.8× 561 0.8× 415 0.7× 240 0.5× 189 5.1k
Silvia S. Pierangeli United States 47 3.1k 1.6× 2.0k 2.2× 758 1.0× 312 0.5× 169 0.4× 137 7.2k

Countries citing papers authored by Mark Weinstein

Since Specialization
Citations

This map shows the geographic impact of Mark Weinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Weinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Weinstein more than expected).

Fields of papers citing papers by Mark Weinstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Weinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Weinstein. The network helps show where Mark Weinstein may publish in the future.

Co-authorship network of co-authors of Mark Weinstein

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Weinstein. A scholar is included among the top collaborators of Mark Weinstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Weinstein. Mark Weinstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Yideng, Joseph W. Jackson, Dorothy E. Scott, et al.. (2020). Detecting factor XIa in immune globulin products: Commutability of international reference materials for traditional and global hemostasis assays. Research and Practice in Thrombosis and Haemostasis. 5(1). 211–222. 3 indexed citations
2.
Hubbard, A. R., Johannes Dodt, Koen Mertens, et al.. (2013). Recommendations on the potency labelling of factor VIII and factor IX concentrates. Journal of Thrombosis and Haemostasis. 11(5). 988–989. 49 indexed citations
3.
Nichols, William L., Margaret E. Rick, Thomas L. Ortel, et al.. (2009). Clinical and laboratory diagnosis of von Willebrand disease: A synopsis of the 2008 NHLBI/NIH guidelines. American Journal of Hematology. 84(6). 366–370. 67 indexed citations
4.
Nichols, William L., MB Hultin, Allison James, et al.. (2008). von Willebrand disease (VWD): evidence‐based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA) 1. Haemophilia. 14(2). 171–232. 630 indexed citations breakdown →
5.
Wood, Lauren V., et al.. (2002). Calibration of the Ph. Eur. BRP Batch 3/Mega 2 (US/FDA) standard for human coagulation factor VIII concentrate for use in the potency assay.. PubMed. 2002(1). 31–64. 10 indexed citations
6.
Lynch, Thomas J., Mark Weinstein, Donald L. Tankersley, Joseph C. Fratantoni, & J.S. Finlayson. (1996). Considerations of pool size in the manufacture of plasma derivatives. Transfusion. 36(9). 770–775. 15 indexed citations
7.
Berg, John, Mark Weinstein, Dempsey S. Springfield, & William Rand. (1995). Results of surgery and doxorubicin chemotherapy in dogs with osteosarcoma. Journal of the American Veterinary Medical Association. 206(10). 1555–1560. 111 indexed citations
8.
Mitroka, James, et al.. (1995). Cerebrospinal Fluid Retrieval in the Conscious Dog: A Methods Development Study. Journal of Investigative Surgery. 8(1). 85–94. 4 indexed citations
9.
Berg, John, Mark Weinstein, Scott H. Schelling, & William Rand. (1992). Treatment of dogs with osteosarcoma by administration of cisplatin after amputation or limb-sparing surgery: 22 cases (1987-1990). Journal of the American Veterinary Medical Association. 200(12). 2005–2008. 91 indexed citations
10.
Ansell, Jack, Robert Lew, Steven P. Ball, et al.. (1992). Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations?. Journal of Thoracic and Cardiovascular Surgery. 104(1). 117–123. 37 indexed citations
11.
12.
Weinstein, Mark. (1990). Multiple Hypopigmented Papules. Archives of Dermatology. 126(8). 1095–1095. 2 indexed citations
13.
Weinstein, Mark. (1990). Multiple hypopigmented papules. Trichodiscoma. Archives of Dermatology. 126(8). 1093–1093. 3 indexed citations
14.
Moake, Joel L., Christine K. Rudy, Joseph H. Troll, et al.. (1986). Case Report: Von Willebrand Factor Abnormalities and Endothelial Cell Perturbation in a Patient with Acute Thrombotic Thrombocytopenic Purpura. The American Journal of the Medical Sciences. 291(1). 47–50. 26 indexed citations
15.
Salzman, E W, Mark Weinstein, Ronald M. Weintraub, et al.. (1986). Treatment with Desmopressin Acetate to Reduce Blood Loss After Cardiac Surgery. Survey of Anesthesiology. 30(6). 371–371. 23 indexed citations
16.
England, Albert C., Mark Weinstein, Jerrold J. Ellner, & Libero Ajello. (1981). Two cases of rhinocerebral zygomycosis (mucormycosis) with common epidemiologic and environmental features.. PubMed. 124(4). 497–8. 20 indexed citations
17.
18.
Weinstein, Mark & Daniel Deykin. (1978). Quantitative Abnormality of an Aα Chain Molecular Weight Form in the Fibrinogen of Cirrhotic Patients. British Journal of Haematology. 40(4). 617–730. 32 indexed citations
19.
Weinstein, Mark, et al.. (1976). Quantitative Determination of Factor‐VIII Protein by Two‐Stage Gel Electrophoresis. British Journal of Haematology. 33(3). 343–355. 14 indexed citations
20.
Patterson, David, Mark Weinstein, Sergio H. Marshall, & David Gillespie. (1971). A new RNA synthesis mutant of E. coli. Biochemical Genetics. 5(6). 563–578. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara M. Alving Breakdown of academic impact, for papers by H K Nieuwenhuis Breakdown of academic impact, for papers by Catherine P.M. Hayward Breakdown of academic impact, for papers by Rodger L. Bick Breakdown of academic impact, for papers by Paul Knöbl Breakdown of academic impact, for papers by Elaine M. Sloand Breakdown of academic impact, for papers by Volker Witt Breakdown of academic impact, for papers by PM Mannucci Breakdown of academic impact, for papers by Bas de Laat Breakdown of academic impact, for papers by Silvia S. Pierangeli
Rankless by CCL
2026